Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease multiple sclerosis
Symptom |spasticity
Sentences 58
PubMedID- 21476822 Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in spain: the '5e' study.
PubMedID- 22354705 Activation of cannabinoid (cb) receptors decreases nociceptive transmission in acute, inflammatory and neuropathic pain states; however, although the use of cannabis derivatives has been recently accepted as a useful alternative for the treatment of spasticity and pain in patients with multiple sclerosis, the effects of cb receptor agonists in muscular pain have hardly been studied.
PubMedID- 24699310 Sativex((r)) is an oromucosal spray used to treat spasticity in multiple sclerosis sufferers in some european countries, the united kingdom, canada and new zealand.
PubMedID- 26445705 spasticity in multiple sclerosis and role of glatiramer acetate treatment.
PubMedID- 20505376 F-wave characteristics as surrogate markers of spasticity in patients with secondary progressive multiple sclerosis.
PubMedID- 23011861 Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids.
PubMedID- 25835097 A breakthrough for the treatment of spasticity in multiple sclerosis.
PubMedID- 21982341 It is used for the symptomatic relief of spasticity associated with multiple sclerosis or with spinal cord injury or disease.

Page: 1 2